Double maintains 1 strategies that include REPL - Replimune Group, Inc.
Yahoo
WOBURN, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees. The Company granted equity awards to 53 employees as a material inducement to commencing their employment with the Company. The inducement awards consist of non-qualified stock options to purchase an aggregate of 98,
SeekingAlpha
Discover Iovance's Q4'24 revenue growth, Proleukin's impact on Amtagvi's future, and how it faces competition like Obsidian's OBX-115.
SeekingAlpha
Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake increases.
Yahoo
WOBURN, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees. The Company granted equity awards to 10 employees as a material inducement to commencing their employment with the Company. The inducement awards consist of non-qualified stock options to purchase an aggregate of 11,
SeekingAlpha
Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click here to read why REPL is a Buy.
Yahoo
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for priority review with a PDUFA date of July 22, 2025 IGNYTE-3 confirmatory trial of RP1(vusolimogene oderparepvec) plus nivolumab in advanced melanoma is enrolling Enrolled first patients in trials evaluating RP2 for the treatment of metastatic uveal melanoma and hepatocellular carcinoma WOBURN, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Replimune Group, I
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -23.11% | $103.42M | 0.59% |
BTAL | -22.42% | $422.73M | 1.43% |
TPMN | -21.48% | $31.05M | 0.65% |
VIXY | -20.47% | $195.31M | 0.85% |
IVOL | -13.47% | $487.86M | 1.02% |
WTMF | -7.86% | $152.15M | 0.65% |
ULST | -7.81% | $624.22M | 0.2% |
FXY | -7.41% | $745.99M | 0.4% |
SHYM | -7.30% | $306.46M | 0.35% |
GBIL | -7.00% | $6.27B | 0.12% |
AGZ | -6.95% | $635.25M | 0.2% |
IBTG | -6.02% | $1.84B | 0.07% |
FTSD | -5.96% | $219.33M | 0.25% |
GSST | -5.71% | $852.75M | 0.16% |
BIL | -5.65% | $46.17B | 0.1356% |
TBLL | -5.48% | $2.47B | 0.08% |
SPTS | -5.07% | $6.24B | 0.03% |
GOVT | -4.88% | $26.82B | 0.05% |
XONE | -4.83% | $626.56M | 0.03% |
VGSH | -4.78% | $22.93B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CATO | -10.33% | $48.79M | -51.59% | 13.60% |
MDLZ | -8.94% | $86.87B | +0.54% | 2.74% |
CCEC | -8.41% | $989.66M | +2.85% | 3.54% |
DG | -8.01% | $19.58B | -39.75% | 2.66% |
EDU | -6.30% | $7.04B | -49.79% | 0.00% |
HSY | -6.11% | $33.55B | -10.84% | 3.29% |
ED | -6.05% | $39.56B | +23.93% | 3.05% |
CHD | -5.64% | $25.68B | +3.24% | 1.10% |
TEF | -5.40% | $25.68B | +9.11% | 6.86% |
FUBO | -5.40% | $973.21M | +96.55% | 0.00% |
AWK | -5.16% | $28.49B | +25.32% | 2.09% |
VHC | -5.10% | $37.17M | +53.05% | 0.00% |
KO | -4.82% | $307.40B | +22.56% | 2.76% |
K | -4.46% | $28.41B | +48.48% | 2.76% |
CPB | -4.29% | $11.37B | -9.86% | 3.99% |
KNOP | -4.21% | $215.05M | +20.81% | 1.63% |
MCK | -3.94% | $86.39B | +31.81% | 0.40% |
CREG | -3.84% | $5.31M | -56.06% | 0.00% |
SMWB | -3.53% | $576.49M | -10.42% | 0.00% |
CL | -3.44% | $76.24B | +9.49% | 2.13% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LPG | <0.01% | $879.20M | -41.44% | 0.00% |
TK | 0.04% | $545.51M | +3.45% | 0.00% |
UFI | -0.05% | $85.15M | -19.86% | 0.00% |
VZ | 0.07% | $184.54B | +10.10% | 6.17% |
JOYY | -0.08% | $1.40B | +19.45% | 0.00% |
CWT | -0.13% | $2.99B | +13.48% | 2.26% |
OTTR | -0.13% | $3.29B | -5.24% | 2.42% |
BNED | -0.15% | $300.70M | -87.61% | 0.00% |
CRCT | 0.16% | $1.04B | +2.73% | 4.10% |
PPL | -0.16% | $25.67B | +30.45% | 2.99% |
FRO | 0.19% | $3.45B | -35.63% | 11.57% |
VRSN | -0.22% | $23.38B | +33.27% | 0.00% |
PARA | 0.22% | $7.17B | -2.46% | 1.87% |
AMT | 0.24% | $99.81B | +18.98% | 3.85% |
DLTR | 0.26% | $15.51B | -42.40% | 0.00% |
PDCO | 0.32% | $2.73B | +21.41% | 2.49% |
CNP | -0.33% | $23.84B | +33.21% | 2.27% |
KR | -0.34% | $45.09B | +23.59% | 1.84% |
NGL | 0.41% | $423.76M | -46.50% | 0.00% |
STNG | -0.42% | $1.78B | -49.71% | 4.46% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RCKT | 42.57% | $561.94M | -78.21% | 0.00% |
ZYME | 37.71% | $745.67M | +14.92% | 0.00% |
KYMR | 37.27% | $1.57B | -32.21% | 0.00% |
XENE | 36.91% | $2.40B | -23.97% | 0.00% |
IDYA | 35.79% | $1.47B | -60.09% | 0.00% |
DNLI | 35.62% | $1.84B | -30.45% | 0.00% |
CLDX | 35.60% | $1.12B | -57.10% | 0.00% |
RYTM | 35.27% | $3.76B | +47.66% | 0.00% |
SNDX | 34.84% | $960.25M | -48.62% | 0.00% |
HALO | 34.38% | $7.44B | +55.97% | 0.00% |
GBIO | 34.18% | $25.95M | -89.53% | 0.00% |
DNTH | 33.57% | $565.72M | -31.98% | 0.00% |
TTC | 33.52% | $6.79B | -20.72% | 2.16% |
KRYS | 33.02% | $4.77B | -4.96% | 0.00% |
MATW | 32.39% | $635.48M | -23.03% | 4.70% |
NGNE | 32.32% | $164.23M | -72.29% | 0.00% |
IMNM | 32.14% | $617.35M | -65.50% | 0.00% |
RDW | 31.95% | $712.24M | +139.38% | 0.00% |
RVMD | 31.94% | $6.64B | -0.97% | 0.00% |
ESTC | 31.92% | $8.34B | -17.90% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TIPX | 0.03% | $1.64B | 0.15% |
STIP | -0.04% | $11.67B | 0.03% |
JBND | -0.06% | $1.74B | 0.25% |
SHM | -0.08% | $3.34B | 0.2% |
SCHZ | -0.10% | $8.44B | 0.03% |
TOTL | 0.11% | $3.47B | 0.55% |
TLT | -0.12% | $47.49B | 0.15% |
HYD | 0.14% | $3.20B | 0.32% |
CANE | 0.14% | $10.54M | 0.29% |
ISTB | -0.24% | $4.47B | 0.06% |
PWZ | -0.24% | $672.24M | 0.28% |
SPTL | -0.25% | $11.15B | 0.03% |
CGMU | 0.27% | $2.97B | 0.27% |
CMBS | -0.27% | $424.61M | 0.25% |
JPST | 0.28% | $29.73B | 0.18% |
CARY | 0.30% | $347.36M | 0.8% |
KMLM | 0.34% | $203.74M | 0.9% |
BNDW | 0.34% | $1.09B | 0.05% |
UITB | -0.35% | $2.34B | 0.39% |
ETHE | 0.37% | $1.81B | 2.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 44.20% | $4.65B | 0.35% |
GNOM | 41.08% | $43.88M | 0.5% |
IBB | 38.82% | $5.06B | 0.45% |
PTH | 36.88% | $97.93M | 0.6% |
ARKG | 36.00% | $898.81M | 0.75% |
PBE | 35.37% | $204.38M | 0.58% |
FBT | 35.28% | $964.65M | 0.56% |
XPH | 35.25% | $139.62M | 0.35% |
IWC | 34.43% | $709.33M | 0.6% |
PINK | 32.87% | $131.13M | 0.5% |
BBH | 32.24% | $321.29M | 0.35% |
IWO | 31.09% | $10.07B | 0.24% |
IWM | 29.92% | $57.88B | 0.19% |
VTWO | 29.91% | $10.25B | 0.07% |
IHE | 29.44% | $527.14M | 0.39% |
KAPR | 29.38% | $163.40M | 0.79% |
KJAN | 28.75% | $292.10M | 0.79% |
ISCG | 28.70% | $598.54M | 0.06% |
VBK | 28.51% | $15.96B | 0.07% |
SCHA | 28.46% | $14.62B | 0.04% |
Current Value
$7.501 Year Return
Current Value
$7.501 Year Return